An approach to contrast enhancement in computed tomography of the brain.
A total of 450 brain examinations were performed using computed tomography before and after intravenous infusion of methylglucamine diatrizoate 30%. In 110 cases involving a documented intracranial lesion, the scans were analyzed to determine the degree and usefulness of contrast enhancement. Enhancement was achieved in a wide variety of neoplastic and non-neoplastic lesions and was found to be of considerable help in detection of abnormality as well as in defining tumor morphology.
D000238:Adenoma, Chromophobe / Q000000981:diagnostic imaging; D001922:Brain Abscess / Q000000981:diagnostic imaging; D001927:Brain Diseases / Q000000981:diagnostic imaging; D001932:Brain Neoplasms / Q000000981:diagnostic imaging; D002528:Cerebellar Neoplasms / Q000000981:diagnostic imaging; D003388:Cranial Fossa, Posterior / Q000000981:diagnostic imaging; D003936:Diagnosis, Computer-Assisted; D003973:Diatrizoate; D005910:Glioma / Q000000981:diagnostic imaging; D006394:Hemangiosarcoma / Q000000981:diagnostic imaging; D006406:Hematoma / Q000000981:diagnostic imaging; D006801:Humans; D002532:Intracranial Aneurysm / Q000000981:diagnostic imaging; D008545:Melanoma / Q000000981:diagnostic imaging / Q000473:pathology; D008579:Meningioma / Q000000981:diagnostic imaging; D009362:Neoplasm Metastasis; D009442:Neurilemmoma / Q000000981:diagnostic imaging; D010524:Peripheral Nervous System Neoplasms / Q000000981:diagnostic imaging; D011856:Radiographic Image Enhancement; D012888:Skull Neoplasms / Q000000981:diagnostic imaging; D013788:Thalamus / Q000000981:diagnostic imaging; D014056:Tomography, X-Ray; D000159:Vestibulocochlear Nerve / Q000000981:diagnostic imaging
D003973:Diatrizoate